The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 12, 2013
Filed:
Jun. 09, 2011
Deborah Sue Mortensen, San Diego, CA (US);
Maria Mercedes Delgado Mederos, San Diego, CA (US);
John Joseph Sapienza, Chula Vista, CA (US);
Ronald J. Albers, San Diego, CA (US);
Branden G. Lee, Vista, CA (US);
Roy Leonard Harris, Iii, San Diego, CA (US);
Graziella Isabel Shevlin, San Diego, CA (US);
Dehua Huang, San Diego, CA (US);
Kimberly Lyn Schwarz, San Diego, CA (US);
Garrick K. Packard, San Diego, CA (US);
Jason Simon Parnes, San Diego, CA (US);
Patrick William Papa, Carlsbad, CA (US);
Lida Radnia Tehrani, San Diego, CA (US);
Sophie Perrin-ninkovic, Carlsbad, CA (US);
Jennifer R. Riggs, Cardiff, CA (US);
Deborah Sue Mortensen, San Diego, CA (US);
Maria Mercedes Delgado Mederos, San Diego, CA (US);
John Joseph Sapienza, Chula Vista, CA (US);
Ronald J. Albers, San Diego, CA (US);
Branden G. Lee, Vista, CA (US);
Roy Leonard Harris, III, San Diego, CA (US);
Graziella Isabel Shevlin, San Diego, CA (US);
Dehua Huang, San Diego, CA (US);
Kimberly Lyn Schwarz, San Diego, CA (US);
Garrick K. Packard, San Diego, CA (US);
Jason Simon Parnes, San Diego, CA (US);
Patrick William Papa, Carlsbad, CA (US);
Lida Radnia Tehrani, San Diego, CA (US);
Sophie Perrin-Ninkovic, Carlsbad, CA (US);
Jennifer R. Riggs, Cardiff, CA (US);
Signal Pharmaceuticals, LLC, San Diego, CA (US);
Abstract
Provided herein are Heteroaryl Compounds having the following structure: wherein R, R, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile